Health and Medicine

Brain researchers in Amsterdam have observed a double control system in the hippocampus. This double control system contributes to the memory and ensures that the brain does not `crash`, as is the case during an epileptic seizure.

The neurobiologists from the University of Amsterdam carried out their observations on the hippocampus of rats. The hippocampus probably plays an important role in converting the short-term memory to the long-term memory.

The hippocampus contains two sorts

Many of today’s medicines were discovered by trial and error: a substance is found which helps alleviate the symptoms of a disease, and it may take years before scientists really understand how it works. Typically they find that a drug has its effects by attaching itself to a particular molecule in a cell and blocking part of its activity, the way you might prevent someone from turning a light on or off by putting a lock over the switch. Scientists now hope to take the opposite approach, and custom-d

New data from a 1998 study to assess the potential risks of chromosomal abnormalities of residents living near landfill sites is detailed in a research letter in this week’s issue of THE LANCET. The findings suggest that the increased risk of chromosomal abnormalities is of a similar magnitude to the increased risk of non-chromosomal abnormalities previously reported.

Previous findings of the EUROHAZCON study (Lancet 1998; 352: 423–27) showed a 33% increase in the risk of non-chromosomal ano

An effective, affordable, and accessible HIV vaccine is 7-10 years away, according to scientists at the Medical Research Council of South Africa, in this week’s BMJ. However, its success depends on a complex interplay of politics, science, and public-private partnerships.

Equitable public-private partnerships between researchers, manufacturers, and distributors and partnerships between rich and poor countries are the best strategy for the development of the vaccine, say the authors. Successf

A team of Italian researchers has demonstrated in the laboratory for the first time that combining two of the newest anti-cancer targeted agents may produce a powerful new combination against breast cancer – and possibly many other cancers as well. Their findings are reported (Thursday 24 January) in the journal Annals of Oncology.*

They found that trastuzumab (Herceptin) and the as yet unlicensed drug ZD1839 (Iressa), act synergistically against two rogue genes commonly involved in breast c

Combining two separate observations of cells in brain tumours could enable doctors to improve the success rate of radiotherapy. Speaking today (23 January) at the Institute of Physics Simulation and Modelling Applied to Medicine conference in London, chemical engineer Dr Norman Kirkby from the University of Surrey will explain how using the correct time intervals between a sequence of low dose radiotherapy sessions could increase the chance of curing brain cancers that tend to resist treatment.